About RNAtopia

RNAtopia was founded on August 1st, 2025—a date chosen with intention. In molecular biology, AUG marks the start codon, the signal to begin translation. For us, it symbolizes the beginning of a new era in RNA therapeutics.

At RNAtopia, our mission is to revolutionize human health through cutting-edge self-amplifying RNA (saRNA) technology. We are committed to overcoming the limitations of conventional mRNA therapies by delivering scalable, durable, and precision-engineered solutions for a wide range of medical challenges.

Our saRNA platform enables:

• Single or multi-component vaccines for infectious diseases-focus on HCV, EBV, CMV, TB, Universal Flu, Nipah, and Disease-X.
• Genetic medicines that are modular, durable, and administered bimonthly.
• Bimonthly injectable GLP-1-like peptides (tetravalent) with enhanced stability and reduced dosing frequency.
• Smart bomb therapeutics—targeted, multi-component constructs designed to selectively destroy cancer cells.

RNAtopia is building a future where RNA isn’t just a molecule—it’s a modular engine for curing disease, restoring health, and transforming lives.